The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Maintenance olaparib after platinum-based chemotherapy in patients (pts) with newly diagnosed advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): Efficacy by surgical and tumor status in the Phase III SOLO1 trial.
 
Cara Amanda Mathews
No Relationships to Disclose
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; Aravive; AstraZeneca; Clovis Oncology; Genentech/Roche; Immunogen; Janssen Oncology; Merck; OncoMed; Pfizer/EMD Serono; Samumed; TESARO; VBL Therapeutics
Speakers' Bureau - AstraZeneca
Research Funding - Abbvie/Stemcentrx (Inst); Advaxis (Inst); Agenus (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Forty Seven (Inst); Genentech (Inst); Immunogen (Inst); Lilly (Inst); Lilly Foundation (Inst); Merck (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Novogen (Inst); PTC Therapeutics (Inst); Regeneron (Inst); Stem CentRx (Inst); Takeda (Inst); Tesaro (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
Other Relationship - AstraZeneca
 
Nicoletta Colombo
Honoraria - AstraZeneca; PharmaMar; Roche/Genentech; Tesaro
Consulting or Advisory Role - AstraZeneca; BioCad; Clovis Oncology; MSD Oncology; Pfizer; PharmaMar; Roche/Genentech; Takeda; Tesaro
 
Giovanni Scambia
No Relationships to Disclose
 
Byoung-Gie Kim
No Relationships to Disclose
 
Ana Oaknin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; ImmunoGen; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; PharmaMar; Roche; Tesaro
 
Michael Friedlander
Honoraria - AstraZeneca; Lilly; MSD; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Lilly; MSD; Takeda
Speakers' Bureau - AstraZeneca
Research Funding - BeiGene (Inst)
 
Alla Sergeevna Lisyanskaya
No Relationships to Disclose
 
Anne Floquet
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche; Tesaro
 
Alexandra Leary
Honoraria - AstraZeneca; Clovis Oncology; Pharmamar; Tesaro
Consulting or Advisory Role - AstraZeneca; Biocad; Clovis Oncology; GamaMabs Pharma; Gritstone Bio; pfizer; Seagen; Tesaro
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Genentech (Inst); inivata (Inst); Merus (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Gabe S. Sonke
Consulting or Advisory Role - Novartis (Inst)
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
 
Charlie Gourley
Honoraria - AstraZeneca; Cor2Ed; Medscape; Tesaro
Consulting or Advisory Role - AstraZeneca; Cor2Ed; Foundation One Inc (Inst); Nucana (Inst); Roche (Inst); Sierra Oncology; Tesaro (Inst)
Research Funding - Aprea AB (Inst); AstraZeneca (Inst); Novartis (Inst); Nucana (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - One patent issued and four pending for a gene expression signature to predict cancer sensitivity to anti-angiogenic therapy. (Inst)
 
Susana N. Banerjee
Honoraria - Roche
Consulting or Advisory Role - AstraZeneca (Inst); AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology (Inst); GamaMabs Pharma; Merck; Roche (Inst); Seagen; Tesaro; Tesaro (Inst)
Research Funding - AstraZeneca (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Tesaro
 
Amit M. Oza
Honoraria - Intas
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - AstraZeneca; Clovis Oncology; Clovis Oncology; Merck; Tesaro
 
Antonio González-Martín
Honoraria - AstraZeneca; Clovis Oncology; MSD; Pfizer; PharmaMar; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; MSD; Pfizer; PharmaMar; Roche; Tesaro
Speakers' Bureau - AstraZeneca; PharmaMar; Roche; Tesaro
Research Funding - Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche; Tesaro
 
Carol Aghajanian
Consulting or Advisory Role - Clovis Oncology; Clovis Oncology; Clovis Oncology; Immunogen; Mateon Therapeutics; Mateon Therapeutics; Tesaro; Tesaro
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst)
 
William Hampton Bradley
Consulting or Advisory Role - Celsion
Travel, Accommodations, Expenses - Roche
 
Elizabeth S. Lowe
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Ralph Bloomfield
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Paul Disilvestro
Consulting or Advisory Role - AstraZeneca; Tesaro
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Genentech (Inst); Janssen Oncology (Inst); Tesaro (Inst)
Expert Testimony - Johnson & Johnson